Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_assertion type Assertion NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_head.
- NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_assertion description "[These results point to IL-6 as an important mediator of bone loss in DMD and suggest that targeted anti-IL-6 therapy may have a positive impact on the bone phenotype in these patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_provenance.
- NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_assertion evidence source_evidence_literature NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_provenance.
- NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_assertion SIO_000772 21509823 NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_provenance.
- NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_assertion wasDerivedFrom befree-20140225 NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_provenance.
- NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_assertion wasGeneratedBy ECO_0000203 NP752251.RAbb_ZAvMw1c0BbNhmJFbBkk_jNrFrpo0TiwISOSHujSg130_provenance.